Insider Transactions in Q1 2022 at Meridian Bioscience Inc (VIVO)
Insider Transaction List (Q1 2022)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Feb 25
2022
|
Andrew S. Kitzmiller Executive Vice President & CFO |
BUY
Open market or private purchase
|
Direct |
4,028
+25.89%
|
$96,672
$24.87 P/Share
|
|
Feb 21
2022
|
Andrew S. Kitzmiller Executive Vice President & CFO |
BUY
Grant, award, or other acquisition
|
Direct |
7,500
+50.0%
|
-
|
|
Feb 15
2022
|
Lourdes Weltzien Executive VP, Life Science |
SELL
Open market or private sale
|
Direct |
20,000
-19.41%
|
$500,000
$25.6 P/Share
|
|
Feb 15
2022
|
Lourdes Weltzien Executive VP, Life Science |
BUY
Exercise of conversion of derivative security
|
Direct |
20,000
+9.18%
|
$280,000
$14.48 P/Share
|
|
Jan 26
2022
|
James M. Anderson Director |
BUY
Grant, award, or other acquisition
|
Direct |
3,012
+13.25%
|
-
|
|
Jan 26
2022
|
Anthony P Bihl Iii Director |
BUY
Grant, award, or other acquisition
|
Direct |
3,012
+16.35%
|
-
|
|
Jan 26
2022
|
Dwight E Ellingwood Director |
BUY
Grant, award, or other acquisition
|
Direct |
3,012
+14.84%
|
-
|
|
Jan 26
2022
|
John Mc Ilwraith Director |
BUY
Grant, award, or other acquisition
|
Direct |
3,012
+12.18%
|
-
|
|
Jan 26
2022
|
John Mc Cune Rice Jr. Director |
BUY
Grant, award, or other acquisition
|
Direct |
3,012
+9.89%
|
-
|
|
Jan 26
2022
|
Catherine Sazdanoff Director |
BUY
Grant, award, or other acquisition
|
Direct |
3,012
+15.5%
|
-
|
|
Jan 26
2022
|
Felicia Williams Director |
BUY
Grant, award, or other acquisition
|
Direct |
3,012
+22.67%
|
-
|
|
Jan 12
2022
|
David Phillips Director |
BUY
Exercise of conversion of derivative security
|
Direct |
7,500
+34.81%
|
$135,000
$18.54 P/Share
|